Bethany Sensenig - 01 Oct 2025 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role: Director
Signature: /s/ Benjamin L. Palleiko, Attorney-in-Fact
Issuer symbol: KALV
Transactions as of: 01 Oct 2025
Net transactions value: $0
Form type: 4
Filing time: 02 Oct 2025, 18:28:21 UTC
Previous filing: 18 Aug 2025
Next filing: 20 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sensenig Bethany	Director	C/O KALVISTA PHARMACEUTICALS, INC., 200 CROSSING BOULEVARD, FRAMINGHAM	/s/ Benjamin L. Palleiko, Attorney-in-Fact	02 Oct 2025	0001899935

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KALV	Stock Option (right to buy)	Award	$0	+45,000		$0.000000	45,000	01 Oct 2025	Common Stock	45,000	$12.05	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests over a 3-year period: 1/36th vests on November 1, 2025, after which 1/36th of the total shares vest monthly, subject to reporting person's continued service through each vesting date.